Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

IRDye800-labeled heterodimeric peptide KSP-QRH 919288G

A heterodimeric peptide consisting of the heptapeptide monomers KSPNPRF (KSP) and QRHKPRE (QRH) targeting human epithelial growth factor receptor type 2 (EGFR2; HER2; ErbB2) and epidermal growth factor receptor (EGFR), with an E3 spacer, labeled with the near-infrared (NIR) fluorophore IRDye800, with potential imaging activity using the scanning fiber endoscope (SFE) imaging system. Upon spraying of the esophagus with IRDye800-labeled heterodimeric peptide KSP-QRH 919288G, the heterodimeric peptide moiety targets and binds to HER2 and EGFR expressed on dysplastic cells in the pre-cancerous mucosa of the esophagus. Upon fluorescence imaging of the fluorophore IRDye800 with the SFE probe, the HER-2- and EGFR-expressing dysplastic cells can be detected. EGFR and HER2 are tyrosine kinase receptors that are overexpressed on the surfaces of various tumor cell types, and they are expressed in esophageal dysplasia.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:IRDye800-labeled KSP/QRH dimer
KSP-QRH-E3-IRDye800
KSP/QRH peptide dimer
peptide 919288G
Code name:919288G
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search